Epidemiology of the metabolic syndrome;Zur Epidemiologie des metabolischen Syndroms

Internist

Volumn 37, Issue 7, 1996, Pages 681-686

  Janka, H U ^a  

^a Zentralkrankenhaus Bremen Nord   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DYSLIPIDEMIA; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; SYNDROME;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HUMANS; HYPERLIPIDEMIAS; INCIDENCE; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK FACTORS; SYNDROME;

EID: 0030002293     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Assmann G, Schultz H (1988) The prospective cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 116: 1713-1724
2. Banerji MA, Lebovitz HE (1993) Insulin action in black Americans with NIDDM. Diabetes Care 15: 1295-1302
3. Bao W, Srinivasan SR, Wattigney WA, Berenson GS (1994) Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood: The Bogalusa Heart Study. Arch Intern Med 154: 1842-1847
4. Byrne CD, Wareham NJ, Day NE, McLeish R, Williams DRR, Hales CN (1995) Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance. Diabetologia 38: 1358-1366
5. Castelli WP (1992) Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 70: 3H-9H
6. DeFronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194
7. Denke MA, Sempos CT, Grundy SM (1993) Excess body weight: an under-recognized contributor to high blood cholesterol levels in white american men. Arch Intern Med 153: 1093-1103
8. Denker PS, Pollock VE (1992) Fasting serum insulin levels in essential hypertension: a meta-analysis. Arch Intern Med 152: 1649-1651
9. Després J-P, Marette A (1994) Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipid 5: 274-289
10. Dieterle P, Fehm H, Ströder W, Henner J, Bottermann P, Schwarz K (1967) Asymptomatischer Diabetes mellitus bei normalgewichtigen Hypertonikern. Dtsch Med Wochenschr 92: 2376-2380
11. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337-343
12. Ferrannini E, Haffner SM, Mitchel BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422
13. Ferrannini E (1995) Unveröffentlichter Vortrag bei der 31. Jahrestagung der EASD, Stockholm
14. Folsom AR, Kaye SA, Sellers TA, Hong C-P, Cerhan JR, Potter JD, Prineas RJ (1993) Body fat distribution and 5-year risk of death in older women. JAMA 269: 483-487
15. Garancini MP, Calori G, Manara E, Izzo A, Ebbli E, Galli L, Boari L, Gallus G (1933) An italian population-based study of the prevalence of diabetes: some methodologic aspects. Diabetes Metab 19: 116-120
16. Godsland IF, Stevenson JC (1995) Insulin resistance: syndrome or tendency? Lancet 346: 100-103
17. Greiser EM (1993) Risk factor trends and cardiovascular mortality risk after 3.5 years of community-based intervention in the German Cardiovascular Prevention Study. Ann Epidemiol 3 [Suppl]: S13-S27
18. Groop L, Ekstrand A, Forsblom C, Widen E, Groop P-H, Teppo A-P, Eriksson J (1993) Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 642-647
19. Grootenhuis PA, Mooy JM, Popp-Snijders C, Bouter LM, Heine RJ (1993) Proinsulin-like molecules in relation to blood lipids and blood pressure in a general caucasian population. Diabetologia 36 [Suppl 1]: A71
20. Hanefeld M, Leonhardt W (1981) Das metabolische Syndrom. Dtsch Gesundheitswesen 36: 545-551
21. Hanefeld M (1993) Typ-II-Diabetes and Hypertonie als Komponenten des metabolischen Syndroms: Konsequenzen für die Therapie. Diabetes Stoffw 2: 396-402
22. Harris MI, Hadden WC, Knowler WC, Bennett PH (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 36: 523-534
23. Harris MI, Modan M (1944) Screening for NIDDM: why is there no national program? Diabetes Care 17: 440-444
24. Hauner H, von Ferber L. Köster I (1992) Schätzung der Diabeteshäufigkeit in der Bundespublik Deutschland anhand von Krankenkassendaten: Sekundäranalyse einer repräsentativen Stichprobe AOK-Versicherter der Stadt Dortmund. Dtsch Med Wochenschr 117: 645-650
25. Helmert U, Janka HU, Strube H (1994) Epidemiologische Befunde zur Häufigkeit des Diabetes mellitus in der Bundesrepublik Deutschland. Diabetes Stoffw 3: 271-277
26. Heseker H (1994) An epidemiological study of food consumption habits in Germany: comparison with other western countries. Mediographia 16: 7-10
27. Janka HU, Standl E, Bloss G, Oberparleiter F, Mehnert H (1978) Zur Epidemiologie der Hypertonie bei Diabetikern. Dtsch Med Wochenschr 103: 1549-1555
28. Janka HU, Balletshofer B, Becker A, Gick MR, Hartmann J, Jung D, Mäckelmann S, Möltner A (1992) Das metabolische Syndrom als potenter kardiovaskulärer Risikofaktor für vorzeitigen Tod bei Typ-II-Diabetikern. Diabetes Stoffw 1: 2-7
29. Kaplan N (1989) The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridemia, hypertension. Arch Intern Med 149: 1514-1520
30. King H, Rewers M for the WHO Ad Hoc Diabetes Reporting Group (1993) Global estimates for prevalence of diabetes mellilus and impaired glucose tolerance in adults. Diabetes Care 16: 157-177
31. Knudsen P, Eriksson J, Lahdenperä S, Kahri J, Groop L, Taskinen M-R and the Botnia Study Group (1995) Changes of lipolytic enzymes cluster with insulin resistance syndrome. Diabetologia 38: 344-350
32. Kohrt WM, Kirwan JH, Staten MA, Bourey RE, King DS, Holloszy JO (1993) Insulin resistance in aging is related to abdominal obesity. Diabetes 42: 273-281
33. Larsson B, Svardsüdd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G (1984) Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men bom in 1913. Br Med J 288: 1401-1404
34. Lillioja S, Mott OM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329: 1988-1992
35. Mann GV (1974) The influence of obesity on health. N Engl J Med 291: 178-185, 226-232
36. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter OJ, Hankinson SE, Henneken CH, Speizer FE (1995) Body weight and mortality among women. N Engl J Med 333:677-685
37. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925-929
38. McKeigue PM, Shah B, Marmot MG (1991) Relationship of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382-386
39. Mehnert H, Kuhlmann H (1968) Hypertonie und Diabetes mellitus. Dtsch Med J 19: 567-571
40. Michaelis D, Jutzi E (1991) Epidemiologie des Diabetes mellitus in der Bevölkerung der ehemaligen DDR: Alters- und geschlechtsspezifische Inzidenz.- und Prävalenztrends im Zeitraum 1960-1987. Z Klin Med 46: 59-64
41. Mitchel BD, Stern MP, Haffner SM (1990) Risk factors for cardiovascular mortality in Mexican Americans and non-hispanic whites. Am J Epidemiol 131: 423-433
42. Mykkänen L, Kuusisto, J, Pyörälä K, Laakso M (1993) Cardiovascular disease risk factors as predictors of Type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36: 553-559
43. Noack R, Johnsen O (1993) Lpidemiologie der Adipositas in den westlichen Industrienationen. Diabetes Stoffw 2: 391-395
44. Orchard TJ (1990) Dyslipoproteinemia and diabetes. Endocrinol Metab Clin North Am 19: 361-380
45. Raitakari OT, Porkka KVK, Rönnemaa T, Knip M, Uhari M, Akerblom HK, Viikari JSA (1995) The role of insulin in clustering of serum lipids and blood pressure in children and adolescents: The Cardiovascular Risk in Young Finns Study. Diabetologia 38: 1042-1050
46. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595-1607
47. Rett K, Wicklmayr M (1993) Das metabolische Syndrom: Eine neue Aufgabe für die Präventivmedizin. Dtsch Med Wochenschr 118: 1407-1411
48. Ritz E, Bühler FR (1991) Insulin Nebensache oder gar Ursache der Hypertonie? Dtsch Med Wochenschr 116: 1930-1932
49. Rönnemaa T, Laakso M, Pyörälä K, Kallio V, Puukka P (1991) High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and non-diabetic subjects. Arterioscler Thromb 11: 80-90
50. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer EJ, Krauss RM (1993) LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88: 381-387
51. Stieber J, Döring A, Keil U (1982) Häufigkeit, Bekanntheits- und Behandlungsgrad der Hypertonie in einer Großstadtbevölkerung. Ergebnisse der Münchner Blutdruck-Studie I. Münch Med Wochenschr 124: 747-752
52. Temple RC, Clark PMS, Nagi DK, Schneider AE, Yudkin JS, Hales CN (1990) Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol 32: 689-693
53. Tenkanen L, Mänttäri M, Manninen V (1995) Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil: experience from the Helsinki Heart Study. Circulation 92: 1779-1785
54. Trenkwalder P, Ruland D, Gebhard J, Lydtin H, Hense H-W (1995) Hypertension and other cardiovascular risk factors in a German population over the age of 65. Nieren Hochdruckkr 24: 425-427
55. Tuomilehto J, Nissinen A, Kivilä S-L, Pekkanen J, Kaarsalo E, Wolf E, Aro A, Punsar S (1986) Prevalence of diabetes mellitus in elderly men aged 65 to 84 years in eastern and western Finland. Diabetologia 29: 611-615
56. Vague J (1956) The degree of masculine differentiation of obesities, a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr 4: 20-34
57. Widen E, Ekstrand A, Saloranta C, Fransilla-Kallunki A, Eriksson J, Schalin-Jäntti C, Groop L (1992) Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia. Diabetologia 35: 1140-1145
58. Wingard DL, Barrett-Connor EL, Ferrara A (1995) Is insulin really a heart disease risk factor? Diabetes Care 18: 1299-1403
59. Zimmet PZ, Collins VR, Dowse GK, Knight LT (1992) Hyperinsulinaemia in youth is a predictor of Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 534-541